Spyre Therapeutics, Inc. (SYRE)
93.19
+3.26
(+3.62%)
USD |
NASDAQ |
Oct 02, 16:00
93.19
0.00 (0.00%)
After-Hours: 20:00
Spyre Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -31.55K% |
| March 31, 2023 | -9.30K% |
| December 31, 2022 | -11.20K% |
| September 30, 2022 | -10.48K% |
| June 30, 2022 | -3.57K% |
| March 31, 2022 | -1.79K% |
| December 31, 2021 | -561.1% |
| September 30, 2021 | -1.45K% |
| June 30, 2021 | -49.87% |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 |
| Date | Value |
|---|---|
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | -395.9% |
| March 31, 2018 | -537.7% |
| December 31, 2017 | -437.4% |
| September 30, 2017 | -624.4% |
| June 30, 2017 | -448.4% |
| March 31, 2017 | -636.2% |
| December 31, 2016 | -439.7% |
| September 30, 2016 | -542.9% |
| June 30, 2016 | -395.5% |
| March 31, 2016 | -529.3% |
| December 31, 2015 | -251.5% |
| September 30, 2015 | -318.1% |
| June 30, 2015 | -41.64% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AbbVie, Inc. | 21.21% |
| Incyte Corp. | 34.98% |
| SELLAS Life Sciences Group, Inc. | -- |
| Relay Therapeutics, Inc. | -23.92K% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -24.75% |
| Return on Assets | -22.38% |
| Return on Invested Capital | -24.75% |